NASDAQ: LFSTLifestance Health Group Inc Stock
$6.70-0.01 (-0.15%)
Updated Apr 17, 2025
LFST Price
$6.70
Fair Value Price
N/A
Market Cap
$2.58B
52 Week Low
$4.64
52 Week High
$8.61
P/E
-44.67x
P/B
1.78x
P/S
2.23x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.25B
Earnings
-$57.44M
Gross Margin
32.2%
Operating Margin
-2.48%
Profit Margin
-4.6%
Debt to Equity
0.47
Operating Cash Flow
$107M
Beta
1.4
Next Earnings
Jun 3, 2025
Ex-Dividend
N/A
Next Dividend
N/A
LFST Overview
LifeStance Health Group Incorporated offers psychiatric evaluations and treatment, psychological and neuropsychological testing, as well as individual, family, and group therapy. The company treats anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It provides care online and in person at centers in 32 states. LifeStance was founded in 2017 and is based in Scottsdale, AZ.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LFST's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
LFST
Ranked#14 of 42
Ranked#14 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.82 | A | |
| $12.51 | A | |
| $174.80 | A |
Be the first to know about important LFST news, forecast changes, insider trades & much more!
LFST News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LFST scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LFST is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LFST is good value based on its book value relative to its share price (1.78x), compared to the US Medical Care Facilities industry average (4.22x)
P/B vs Industry Valuation
LFST is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more LFST due diligence checks available for Premium users.
Valuation
LFST price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-44.67x
Industry
14.77x
Market
27.98x
LFST price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.78x
Industry
4.22x
LFST is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LFST's financial health
Profit margin
Revenue
$325.5M
Net Income
-$7.1M
Profit Margin
-2.2%
LFST's Earnings (EBIT) of -$31.08M... subscribe to Premium to read more.
Interest Coverage Financials
LFST's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.1B
Liabilities
$672.0M
Debt to equity
0.47
LFST's short-term assets ($312.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LFST's long-term liabilities ($443.13M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LFST's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$62.3M
Investing
-$6.3M
Financing
-$4.1M
LFST's operating cash flow ($107.26M)... subscribe to Premium to read more.
Debt Coverage Financials
LFST vs Medical Care Facility Stocks
Lifestance Health Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.